▶ 調査レポート

世界の遺伝子検出用個別化癌治療市場規模・現状・予測(2021年-2027年)

• 英文タイトル:Global Gene Detection for Individualized Cancer Therapy Market Size, Status and Forecast 2021-2027

QYResearchが調査・発行した産業分析レポートです。世界の遺伝子検出用個別化癌治療市場規模・現状・予測(2021年-2027年) / Global Gene Detection for Individualized Cancer Therapy Market Size, Status and Forecast 2021-2027 / QFJ1-4246資料のイメージです。• レポートコード:QFJ1-4246
• 出版社/出版日:QYResearch / 2021年6月
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、98ページ
• 納品方法:Eメール(納期:3日)
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥577,200 (USD3,900)▷ お問い合わせ
  Multi User¥865,800 (USD5,850)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYResearch社発行の本調査レポートでは、遺伝子検出用個別化癌治療の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(遺伝子スクリーニング、生殖遺伝子検査、診断検査、遺伝子保因者検査、症状発生前検査)、用途別市場規模(病院、クリニック、診断センター)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・遺伝子検出用個別化癌治療の市場動向
・企業の競争状況、市場シェア
・遺伝子検出用個別化癌治療の種類別市場規模と予測2016-2027(遺伝子スクリーニング、生殖遺伝子検査、診断検査、遺伝子保因者検査、症状発生前検査)
・遺伝子検出用個別化癌治療の用途別市場規模と予測2016-2027(病院、クリニック、診断センター)
・遺伝子検出用個別化癌治療の北米市場規模2016-2027(アメリカ、カナダ)
・遺伝子検出用個別化癌治療の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・遺伝子検出用個別化癌治療のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・遺伝子検出用個別化癌治療の中南米市場規模2016-2027(メキシコ、ブラジル)
・遺伝子検出用個別化癌治療の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Premed、Yin Feng Gene、United Gene Group、Geneis、Topgen、Annoroad、Gene+、Sanvalley、Sansure)
・結論

A method to provide patients with individualized treatment of cancer tumors

Market Analysis and Insights: Global Gene Detection for Individualized Cancer Therapy Market
The global Gene Detection for Individualized Cancer Therapy market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Gene Detection for Individualized Cancer Therapy market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Gene Detection for Individualized Cancer Therapy market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Gene Detection for Individualized Cancer Therapy market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Gene Detection for Individualized Cancer Therapy market.

Global Gene Detection for Individualized Cancer Therapy Scope and Market Size
Gene Detection for Individualized Cancer Therapy market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Gene Detection for Individualized Cancer Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Genetic Screening
Reproductive Genetic Testing
Diagnostic Test
Gene carrier Test
Testing Before Symptoms Appear

Segment by Application
Hospital
Clinic
Diagnostic Center

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Premed
Yin Feng Gene
United Gene Group
Geneis
Topgen
Annoroad
Gene+
Sanvalley
Sansure

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gene Detection for Individualized Cancer Therapy Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Genetic Screening
1.2.3 Reproductive Genetic Testing
1.2.4 Diagnostic Test
1.2.5 Gene carrier Test
1.2.6 Testing Before Symptoms Appear
1.3 Market by Application
1.3.1 Global Gene Detection for Individualized Cancer Therapy Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Diagnostic Center
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Gene Detection for Individualized Cancer Therapy Market Perspective (2016-2027)
2.2 Gene Detection for Individualized Cancer Therapy Growth Trends by Regions
2.2.1 Gene Detection for Individualized Cancer Therapy Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Gene Detection for Individualized Cancer Therapy Historic Market Share by Regions (2016-2021)
2.2.3 Gene Detection for Individualized Cancer Therapy Forecasted Market Size by Regions (2022-2027)
2.3 Gene Detection for Individualized Cancer Therapy Industry Dynamic
2.3.1 Gene Detection for Individualized Cancer Therapy Market Trends
2.3.2 Gene Detection for Individualized Cancer Therapy Market Drivers
2.3.3 Gene Detection for Individualized Cancer Therapy Market Challenges
2.3.4 Gene Detection for Individualized Cancer Therapy Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Gene Detection for Individualized Cancer Therapy Players by Revenue
3.1.1 Global Top Gene Detection for Individualized Cancer Therapy Players by Revenue (2016-2021)
3.1.2 Global Gene Detection for Individualized Cancer Therapy Revenue Market Share by Players (2016-2021)
3.2 Global Gene Detection for Individualized Cancer Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Gene Detection for Individualized Cancer Therapy Revenue
3.4 Global Gene Detection for Individualized Cancer Therapy Market Concentration Ratio
3.4.1 Global Gene Detection for Individualized Cancer Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gene Detection for Individualized Cancer Therapy Revenue in 2020
3.5 Gene Detection for Individualized Cancer Therapy Key Players Head office and Area Served
3.6 Key Players Gene Detection for Individualized Cancer Therapy Product Solution and Service
3.7 Date of Enter into Gene Detection for Individualized Cancer Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Gene Detection for Individualized Cancer Therapy Breakdown Data by Type
4.1 Global Gene Detection for Individualized Cancer Therapy Historic Market Size by Type (2016-2021)
4.2 Global Gene Detection for Individualized Cancer Therapy Forecasted Market Size by Type (2022-2027)

5 Gene Detection for Individualized Cancer Therapy Breakdown Data by Application
5.1 Global Gene Detection for Individualized Cancer Therapy Historic Market Size by Application (2016-2021)
5.2 Global Gene Detection for Individualized Cancer Therapy Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Gene Detection for Individualized Cancer Therapy Market Size (2016-2027)
6.2 North America Gene Detection for Individualized Cancer Therapy Market Size by Type
6.2.1 North America Gene Detection for Individualized Cancer Therapy Market Size by Type (2016-2021)
6.2.2 North America Gene Detection for Individualized Cancer Therapy Market Size by Type (2022-2027)
6.2.3 North America Gene Detection for Individualized Cancer Therapy Market Size by Type (2016-2027)
6.3 North America Gene Detection for Individualized Cancer Therapy Market Size by Application
6.3.1 North America Gene Detection for Individualized Cancer Therapy Market Size by Application (2016-2021)
6.3.2 North America Gene Detection for Individualized Cancer Therapy Market Size by Application (2022-2027)
6.3.3 North America Gene Detection for Individualized Cancer Therapy Market Size by Application (2016-2027)
6.4 North America Gene Detection for Individualized Cancer Therapy Market Size by Country
6.4.1 North America Gene Detection for Individualized Cancer Therapy Market Size by Country (2016-2021)
6.4.2 North America Gene Detection for Individualized Cancer Therapy Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Gene Detection for Individualized Cancer Therapy Market Size (2016-2027)
7.2 Europe Gene Detection for Individualized Cancer Therapy Market Size by Type
7.2.1 Europe Gene Detection for Individualized Cancer Therapy Market Size by Type (2016-2021)
7.2.2 Europe Gene Detection for Individualized Cancer Therapy Market Size by Type (2022-2027)
7.2.3 Europe Gene Detection for Individualized Cancer Therapy Market Size by Type (2016-2027)
7.3 Europe Gene Detection for Individualized Cancer Therapy Market Size by Application
7.3.1 Europe Gene Detection for Individualized Cancer Therapy Market Size by Application (2016-2021)
7.3.2 Europe Gene Detection for Individualized Cancer Therapy Market Size by Application (2022-2027)
7.3.3 Europe Gene Detection for Individualized Cancer Therapy Market Size by Application (2016-2027)
7.4 Europe Gene Detection for Individualized Cancer Therapy Market Size by Country
7.4.1 Europe Gene Detection for Individualized Cancer Therapy Market Size by Country (2016-2021)
7.4.2 Europe Gene Detection for Individualized Cancer Therapy Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Gene Detection for Individualized Cancer Therapy Market Size (2016-2027)
8.2 Asia-Pacific Gene Detection for Individualized Cancer Therapy Market Size by Type
8.2.1 Asia-Pacific Gene Detection for Individualized Cancer Therapy Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Gene Detection for Individualized Cancer Therapy Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Gene Detection for Individualized Cancer Therapy Market Size by Type (2016-2027)
8.3 Asia-Pacific Gene Detection for Individualized Cancer Therapy Market Size by Application
8.3.1 Asia-Pacific Gene Detection for Individualized Cancer Therapy Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Gene Detection for Individualized Cancer Therapy Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Gene Detection for Individualized Cancer Therapy Market Size by Application (2016-2027)
8.4 Asia-Pacific Gene Detection for Individualized Cancer Therapy Market Size by Region
8.4.1 Asia-Pacific Gene Detection for Individualized Cancer Therapy Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Gene Detection for Individualized Cancer Therapy Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Gene Detection for Individualized Cancer Therapy Market Size (2016-2027)
9.2 Latin America Gene Detection for Individualized Cancer Therapy Market Size by Type
9.2.1 Latin America Gene Detection for Individualized Cancer Therapy Market Size by Type (2016-2021)
9.2.2 Latin America Gene Detection for Individualized Cancer Therapy Market Size by Type (2022-2027)
9.2.3 Latin America Gene Detection for Individualized Cancer Therapy Market Size by Type (2016-2027)
9.3 Latin America Gene Detection for Individualized Cancer Therapy Market Size by Application
9.3.1 Latin America Gene Detection for Individualized Cancer Therapy Market Size by Application (2016-2021)
9.3.2 Latin America Gene Detection for Individualized Cancer Therapy Market Size by Application (2022-2027)
9.3.3 Latin America Gene Detection for Individualized Cancer Therapy Market Size by Application (2016-2027)
9.4 Latin America Gene Detection for Individualized Cancer Therapy Market Size by Country
9.4.1 Latin America Gene Detection for Individualized Cancer Therapy Market Size by Country (2016-2021)
9.4.2 Latin America Gene Detection for Individualized Cancer Therapy Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Gene Detection for Individualized Cancer Therapy Market Size (2016-2027)
10.2 Middle East & Africa Gene Detection for Individualized Cancer Therapy Market Size by Type
10.2.1 Middle East & Africa Gene Detection for Individualized Cancer Therapy Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Gene Detection for Individualized Cancer Therapy Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Gene Detection for Individualized Cancer Therapy Market Size by Type (2016-2027)
10.3 Middle East & Africa Gene Detection for Individualized Cancer Therapy Market Size by Application
10.3.1 Middle East & Africa Gene Detection for Individualized Cancer Therapy Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Gene Detection for Individualized Cancer Therapy Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Gene Detection for Individualized Cancer Therapy Market Size by Application (2016-2027)
10.4 Middle East & Africa Gene Detection for Individualized Cancer Therapy Market Size by Country
10.4.1 Middle East & Africa Gene Detection for Individualized Cancer Therapy Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Gene Detection for Individualized Cancer Therapy Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Premed
11.1.1 Premed Company Details
11.1.2 Premed Business Overview
11.1.3 Premed Gene Detection for Individualized Cancer Therapy Introduction
11.1.4 Premed Revenue in Gene Detection for Individualized Cancer Therapy Business (2016-2021)
11.1.5 Premed Recent Development
11.2 Yin Feng Gene
11.2.1 Yin Feng Gene Company Details
11.2.2 Yin Feng Gene Business Overview
11.2.3 Yin Feng Gene Gene Detection for Individualized Cancer Therapy Introduction
11.2.4 Yin Feng Gene Revenue in Gene Detection for Individualized Cancer Therapy Business (2016-2021)
11.2.5 Yin Feng Gene Recent Development
11.3 United Gene Group
11.3.1 United Gene Group Company Details
11.3.2 United Gene Group Business Overview
11.3.3 United Gene Group Gene Detection for Individualized Cancer Therapy Introduction
11.3.4 United Gene Group Revenue in Gene Detection for Individualized Cancer Therapy Business (2016-2021)
11.3.5 United Gene Group Recent Development
11.4 Geneis
11.4.1 Geneis Company Details
11.4.2 Geneis Business Overview
11.4.3 Geneis Gene Detection for Individualized Cancer Therapy Introduction
11.4.4 Geneis Revenue in Gene Detection for Individualized Cancer Therapy Business (2016-2021)
11.4.5 Geneis Recent Development
11.5 Topgen
11.5.1 Topgen Company Details
11.5.2 Topgen Business Overview
11.5.3 Topgen Gene Detection for Individualized Cancer Therapy Introduction
11.5.4 Topgen Revenue in Gene Detection for Individualized Cancer Therapy Business (2016-2021)
11.5.5 Topgen Recent Development
11.6 Annoroad
11.6.1 Annoroad Company Details
11.6.2 Annoroad Business Overview
11.6.3 Annoroad Gene Detection for Individualized Cancer Therapy Introduction
11.6.4 Annoroad Revenue in Gene Detection for Individualized Cancer Therapy Business (2016-2021)
11.6.5 Annoroad Recent Development
11.7 Gene+
11.7.1 Gene+ Company Details
11.7.2 Gene+ Business Overview
11.7.3 Gene+ Gene Detection for Individualized Cancer Therapy Introduction
11.7.4 Gene+ Revenue in Gene Detection for Individualized Cancer Therapy Business (2016-2021)
11.7.5 Gene+ Recent Development
11.8 Sanvalley
11.8.1 Sanvalley Company Details
11.8.2 Sanvalley Business Overview
11.8.3 Sanvalley Gene Detection for Individualized Cancer Therapy Introduction
11.8.4 Sanvalley Revenue in Gene Detection for Individualized Cancer Therapy Business (2016-2021)
11.8.5 Sanvalley Recent Development
11.9 Sansure
11.9.1 Sansure Company Details
11.9.2 Sansure Business Overview
11.9.3 Sansure Gene Detection for Individualized Cancer Therapy Introduction
11.9.4 Sansure Revenue in Gene Detection for Individualized Cancer Therapy Business (2016-2021)
11.9.5 Sansure Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Gene Detection for Individualized Cancer Therapy Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Genetic Screening
Table 3. Key Players of Reproductive Genetic Testing
Table 4. Key Players of Diagnostic Test
Table 5. Key Players of Gene carrier Test
Table 6. Key Players of Testing Before Symptoms Appear
Table 7. Global Gene Detection for Individualized Cancer Therapy Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Gene Detection for Individualized Cancer Therapy Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Gene Detection for Individualized Cancer Therapy Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Gene Detection for Individualized Cancer Therapy Market Share by Regions (2016-2021)
Table 11. Global Gene Detection for Individualized Cancer Therapy Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Gene Detection for Individualized Cancer Therapy Market Share by Regions (2022-2027)
Table 13. Gene Detection for Individualized Cancer Therapy Market Trends
Table 14. Gene Detection for Individualized Cancer Therapy Market Drivers
Table 15. Gene Detection for Individualized Cancer Therapy Market Challenges
Table 16. Gene Detection for Individualized Cancer Therapy Market Restraints
Table 17. Global Gene Detection for Individualized Cancer Therapy Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Gene Detection for Individualized Cancer Therapy Market Share by Players (2016-2021)
Table 19. Global Top Gene Detection for Individualized Cancer Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gene Detection for Individualized Cancer Therapy as of 2020)
Table 20. Ranking of Global Top Gene Detection for Individualized Cancer Therapy Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Gene Detection for Individualized Cancer Therapy Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Gene Detection for Individualized Cancer Therapy Product Solution and Service
Table 24. Date of Enter into Gene Detection for Individualized Cancer Therapy Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Gene Detection for Individualized Cancer Therapy Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Gene Detection for Individualized Cancer Therapy Revenue Market Share by Type (2016-2021)
Table 28. Global Gene Detection for Individualized Cancer Therapy Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Gene Detection for Individualized Cancer Therapy Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Gene Detection for Individualized Cancer Therapy Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Gene Detection for Individualized Cancer Therapy Revenue Market Share by Application (2016-2021)
Table 32. Global Gene Detection for Individualized Cancer Therapy Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Gene Detection for Individualized Cancer Therapy Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Gene Detection for Individualized Cancer Therapy Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Gene Detection for Individualized Cancer Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Gene Detection for Individualized Cancer Therapy Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Gene Detection for Individualized Cancer Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Gene Detection for Individualized Cancer Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Gene Detection for Individualized Cancer Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Gene Detection for Individualized Cancer Therapy Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Gene Detection for Individualized Cancer Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Gene Detection for Individualized Cancer Therapy Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Gene Detection for Individualized Cancer Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Gene Detection for Individualized Cancer Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Gene Detection for Individualized Cancer Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Gene Detection for Individualized Cancer Therapy Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Gene Detection for Individualized Cancer Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Gene Detection for Individualized Cancer Therapy Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Gene Detection for Individualized Cancer Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Gene Detection for Individualized Cancer Therapy Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Gene Detection for Individualized Cancer Therapy Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Gene Detection for Individualized Cancer Therapy Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Gene Detection for Individualized Cancer Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Gene Detection for Individualized Cancer Therapy Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Gene Detection for Individualized Cancer Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Gene Detection for Individualized Cancer Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Gene Detection for Individualized Cancer Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Gene Detection for Individualized Cancer Therapy Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Gene Detection for Individualized Cancer Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Gene Detection for Individualized Cancer Therapy Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Gene Detection for Individualized Cancer Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Gene Detection for Individualized Cancer Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Gene Detection for Individualized Cancer Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 64. Premed Company Details
Table 65. Premed Business Overview
Table 66. Premed Gene Detection for Individualized Cancer Therapy Product
Table 67. Premed Revenue in Gene Detection for Individualized Cancer Therapy Business (2016-2021) & (US$ Million)
Table 68. Premed Recent Development
Table 69. Yin Feng Gene Company Details
Table 70. Yin Feng Gene Business Overview
Table 71. Yin Feng Gene Gene Detection for Individualized Cancer Therapy Product
Table 72. Yin Feng Gene Revenue in Gene Detection for Individualized Cancer Therapy Business (2016-2021) & (US$ Million)
Table 73. Yin Feng Gene Recent Development
Table 74. United Gene Group Company Details
Table 75. United Gene Group Business Overview
Table 76. United Gene Group Gene Detection for Individualized Cancer Therapy Product
Table 77. United Gene Group Revenue in Gene Detection for Individualized Cancer Therapy Business (2016-2021) & (US$ Million)
Table 78. United Gene Group Recent Development
Table 79. Geneis Company Details
Table 80. Geneis Business Overview
Table 81. Geneis Gene Detection for Individualized Cancer Therapy Product
Table 82. Geneis Revenue in Gene Detection for Individualized Cancer Therapy Business (2016-2021) & (US$ Million)
Table 83. Geneis Recent Development
Table 84. Topgen Company Details
Table 85. Topgen Business Overview
Table 86. Topgen Gene Detection for Individualized Cancer Therapy Product
Table 87. Topgen Revenue in Gene Detection for Individualized Cancer Therapy Business (2016-2021) & (US$ Million)
Table 88. Topgen Recent Development
Table 89. Annoroad Company Details
Table 90. Annoroad Business Overview
Table 91. Annoroad Gene Detection for Individualized Cancer Therapy Product
Table 92. Annoroad Revenue in Gene Detection for Individualized Cancer Therapy Business (2016-2021) & (US$ Million)
Table 93. Annoroad Recent Development
Table 94. Gene+ Company Details
Table 95. Gene+ Business Overview
Table 96. Gene+ Gene Detection for Individualized Cancer Therapy Product
Table 97. Gene+ Revenue in Gene Detection for Individualized Cancer Therapy Business (2016-2021) & (US$ Million)
Table 98. Gene+ Recent Development
Table 99. Sanvalley Company Details
Table 100. Sanvalley Business Overview
Table 101. Sanvalley Revenue in Gene Detection for Individualized Cancer Therapy Business (2016-2021) & (US$ Million)
Table 102. Sanvalley Recent Development
Table 103. Sansure Company Details
Table 104. Sansure Business Overview
Table 105. Sansure Gene Detection for Individualized Cancer Therapy Product
Table 106. Sansure Revenue in Gene Detection for Individualized Cancer Therapy Business (2016-2021) & (US$ Million)
Table 107. Sansure Recent Development
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Gene Detection for Individualized Cancer Therapy Market Share by Type: 2020 VS 2027
Figure 2. Genetic Screening Features
Figure 3. Reproductive Genetic Testing Features
Figure 4. Diagnostic Test Features
Figure 5. Gene carrier Test Features
Figure 6. Testing Before Symptoms Appear Features
Figure 7. Global Gene Detection for Individualized Cancer Therapy Market Share by Application: 2020 VS 2027
Figure 8. Hospital Case Studies
Figure 9. Clinic Case Studies
Figure 10. Diagnostic Center Case Studies
Figure 11. Gene Detection for Individualized Cancer Therapy Report Years Considered
Figure 12. Global Gene Detection for Individualized Cancer Therapy Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Gene Detection for Individualized Cancer Therapy Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Gene Detection for Individualized Cancer Therapy Market Share by Regions: 2020 VS 2027
Figure 15. Global Gene Detection for Individualized Cancer Therapy Market Share by Regions (2022-2027)
Figure 16. Global Gene Detection for Individualized Cancer Therapy Market Share by Players in 2020
Figure 17. Global Top Gene Detection for Individualized Cancer Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gene Detection for Individualized Cancer Therapy as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Gene Detection for Individualized Cancer Therapy Revenue in 2020
Figure 19. Global Gene Detection for Individualized Cancer Therapy Revenue Market Share by Type (2016-2021)
Figure 20. Global Gene Detection for Individualized Cancer Therapy Revenue Market Share by Type (2022-2027)
Figure 21. North America Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Gene Detection for Individualized Cancer Therapy Market Share by Type (2016-2027)
Figure 23. North America Gene Detection for Individualized Cancer Therapy Market Share by Application (2016-2027)
Figure 24. North America Gene Detection for Individualized Cancer Therapy Market Share by Country (2016-2027)
Figure 25. United States Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Gene Detection for Individualized Cancer Therapy Market Share by Type (2016-2027)
Figure 29. Europe Gene Detection for Individualized Cancer Therapy Market Share by Application (2016-2027)
Figure 30. Europe Gene Detection for Individualized Cancer Therapy Market Share by Country (2016-2027)
Figure 31. Germany Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Gene Detection for Individualized Cancer Therapy Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Gene Detection for Individualized Cancer Therapy Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Gene Detection for Individualized Cancer Therapy Market Share by Region (2016-2027)
Figure 41. China Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Gene Detection for Individualized Cancer Therapy Market Share by Type (2016-2027)
Figure 49. Latin America Gene Detection for Individualized Cancer Therapy Market Share by Application (2016-2027)
Figure 50. Latin America Gene Detection for Individualized Cancer Therapy Market Share by Country (2016-2027)
Figure 51. Mexico Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Gene Detection for Individualized Cancer Therapy Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Gene Detection for Individualized Cancer Therapy Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Gene Detection for Individualized Cancer Therapy Market Share by Country (2016-2027)
Figure 57. Turkey Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Premed Revenue Growth Rate in Gene Detection for Individualized Cancer Therapy Business (2016-2021)
Figure 61. Yin Feng Gene Revenue Growth Rate in Gene Detection for Individualized Cancer Therapy Business (2016-2021)
Figure 62. United Gene Group Revenue Growth Rate in Gene Detection for Individualized Cancer Therapy Business (2016-2021)
Figure 63. Geneis Revenue Growth Rate in Gene Detection for Individualized Cancer Therapy Business (2016-2021)
Figure 64. Topgen Revenue Growth Rate in Gene Detection for Individualized Cancer Therapy Business (2016-2021)
Figure 65. Annoroad Revenue Growth Rate in Gene Detection for Individualized Cancer Therapy Business (2016-2021)
Figure 66. Gene+ Revenue Growth Rate in Gene Detection for Individualized Cancer Therapy Business (2016-2021)
Figure 67. Sanvalley Revenue Growth Rate in Gene Detection for Individualized Cancer Therapy Business (2016-2021)
Figure 68. Sansure Revenue Growth Rate in Gene Detection for Individualized Cancer Therapy Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed